Gyre Therapeutics (GYRE) - News Mentions

Sign up to add (GYRE) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 2 0%
Gilead Sciences
Gilead Sciences
GILD		 0 100%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 1 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 100%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
November 12
Gyre Therapeutics : Reports Third Quarter 2024 and Year To Date Financial Results and Provides Business Update Form 8 K
November 12
Gyre Therapeutics Breaks Above 200-Day Moving Average - Bullish for GYRE
October 24
Gyre Therapeutics (NASDAQ:GYRE) Trading Down 3.8% - Time to Sell?
October 22
Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis
October 22
Renaissance Technologies LLC Makes New $166,000 Investment in Gyre Therapeutics, Inc. (NASDAQ:GYRE)
October 14
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up – Here’s What Happened
October 10
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up - Time to Buy?
October 8
Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) market cap dropped US$51m last week; Public companies bore the brunt
October 4
Gyre Therapeutics (NASDAQ:GYRE) Trading Up 3.3%
October 3
Gyre Therapeutics (NASDAQ:GYRE) Trading 3.3% Higher
October 3
Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference
October 1
WINTON GROUP Ltd Invests $220,000 in Gyre Therapeutics, Inc. (NASDAQ:GYRE)
September 19
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Down 7.0% in August
September 19
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 4.9%
September 18
Analyzing Context Therapeutics (NASDAQ:CNTX) and Gyre Therapeutics (NASDAQ:GYRE)
September 11

How often is Gyre Therapeutics mentioned in the news?

Gyre Therapeutics was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Gyre Therapeutics performing compared to its industry peers?

Gyre Therapeutics underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Gyre Therapeutics in the last month?

There has been no significant change in the number of news mentions for Gyre Therapeutics' compared to the last month.

Why is it important to track news mentions for Gyre Therapeutics?

By monitoring mentions in the news for Gyre Therapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Gyre Therapeutics, ultimately improving their investment strategies.

Sign up and get more insights on Gyre Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact